Neuroendocrinology News

Endocrine Today has compiled a list of the top 10 news reports posted from meeting news coverage during the first few months of 2019.

Endocrine Today has compiled a list of the top five news stories posted from the American Association of Clinical Endocrinologists Scientific & Clinical Congress, held April 24-28, 2019, in Los Angeles.

LOS ANGELES — Three widely available serum steroid precursor measurements are highly predictive for diagnosing adrenal cortical carcinoma and are also useful to differentiate patients with subtypes of Cushing’s syndrome and nonfunctional adrenal tumors, according to study data presented at the AACE Annual Scientific and Clinical Congress.

In this video exclusive, Endocrine Today Editorial Board Member Maria Fleseriu, MD, FACE, professor of neurological surgery and professor of medicine in the division of endocrinology, diabetes and clinical nutrition in the School of Medicine at Oregon Health & Science University and director of the OHSU Northwest Pituitary Center, discusses why mild Cushing’s syndrome matters.

LOS ANGELES — Complete tumor resection is not reached in approximately one-quarter of adults with acromegaly after their first surgery, and this is particularly frequent in those with granulated adenomas, according to findings presented at the AACE Annual Scientific and Clinical Congress.

LOS ANGELES — More than a century has passed since the neurosurgeon and pathologist Harvey Cushing first discovered the disease that would eventually bear his name, but only recently have several key discoveries offered patients with the condition real hope for a cure, according to a speaker here.

In this video exclusive, Susan Samson, MD, PhD, FRCPC, FACE, associate professor in the department of endocrinology, diabetes and metabolism at Baylor College of Medicine in Houston and program chair for the American Association of Clinical Endocrinologists annual meeting describes highlights of this year’s sessions.

Endocrine Today has compiled a list of recent FDA news stories relating to endocrine practice. Drugs under consideration included those for osteoporosis, diabetes, overweight and obesity, hypoactive sexual desire disorder and hypogonadism.

Strongbridge Biopharma announced positive top-line results this week demonstrating the safety and efficacy of levoketoconazole, a steroidogenesis inhibitor used to treat endogenous Cushing’s syndrome, according to a company press release.

NEW ORLEANS —In this video exclusive, Maria Fleseriu, MD, professor of neurological surgery and professor of medicine in the division of endocrinology, diabetes and clinical nutrition in the School of Medicine at Oregon Health & Science University and director of the OHSU Northwest Pituitary Center, discusses management of hypopituitarism during pregnancy and an upcoming study of effects of growth hormone supplementation.